Alector, Dimension raise Series A rounds; Discovery Labs sells $50m in stock; BioMarin, Clovis start PARP inhibitor studies; Array takes ARRY-502 into Phase III; CEL-SCI seeks arbitration with CRO; Otonomy buys tinnitus IP; and GlobeImmune withdraws IPO.
Alector raises Series A cash, taps Adimab antibody discovery engine
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?